the cliff
Patent cliff
Drugs ranked by the soonest barrier to generic / biosimilar entry. Each row shows the earliest-expiring patent OR FDA exclusivity for that drug — whichever falls first determines when competitive pressure begins.
- Dec 9, 20282.4yGAINRecarbrio(cilastatin sodium + imipenem + relebactam)$MRKMerck & Co., Inc.
- Dec 11, 20282.4yGAINBlujepagepotidacin mesylateGlaxoSmithKline LLC
- Dec 14, 20282.4ypatentCEFIXIMECEFIXIMELupin Ltd
- Dec 15, 20282.4ypatentQutenzacapsaicinGrunenthal GmbH
- Dec 16, 20282.4ypatentCARIPRAZINE HYDROCHLORIDECARIPRAZINE HYDROCHLORIDE$ABBVAbbVie Inc.
- Dec 16, 20282.4yNPRevatiosildenafil citrate$VTRSViatris Inc
- Dec 18, 20282.4yNCEFilsuvezbirch triterpenesChiesi USA Inc
- Dec 19, 20282.4yNPPAccruferferric maltolShield TX (UK) Ltd
- Dec 19, 20282.4yI-979JascaydnerandomilastBoehringer Ingelheim International GmbH
- Dec 21, 20282.4yNCEWainuaeplontersen sodium$AZNASTRAZENECA PLC
- Jan 5, 20292.5yNCEZelsuvmiberdazimer sodium [INN]$PTHSPelthos Therapeutics Inc.
- Jan 5, 20292.5ypatentCopiktraduvelisibSecura Bio Inc
- Jan 7, 20292.5ypatentLAMOTRIGINELAMOTRIGINEIpca Pharmaceuticals Inc
- Jan 21, 20292.5yD-198VerquvovericiguatMerck Sharp & Dohme LLC
- Jan 28, 20292.6yNPYuvezzi(brimonidine tartrate + carbachol [INN])Tenpoint Therapeutics Ltd
- Jan 28, 20292.6ypatentMyfembree(estradiol + norethindrone acetate + relugolix)Sumitomo Pharma America Inc
- Jan 28, 20292.6ypatentOrgovyxrelugolixSumitomo Pharma America Inc
- Feb 3, 20292.6ypatentPROGESTERONEPROGESTERONEIBSA Institut Biochimique SA
- Feb 3, 20292.6ypatentInbrijalevodopaPureIMS BV
- Feb 9, 20292.6ypatentEnsacoveensartinib hydrochlorideXcovery Holdings Inc
- Feb 10, 20292.6ypatentFirmagondegarelix acetateFerring Pharmaceuticals Inc
- Feb 13, 20292.6yNCERapiblyklandiolol hydrochlorideAOP Health
- Feb 21, 20292.6ypatentVyzultalatanoprostene bunod$BLCOBausch & Lomb Corp
- Feb 24, 20292.6ypatentCataflamdiclofenac potassiumAmici Pharmaceuticals LLC
- Mar 5, 20292.7ypatentBromfenac Sodiumbromfenac sodiumSentiss Pharmaceuticals LLC
- Mar 10, 20292.7ypatentOlumiantbaricitinibEli Lilly and Co
- Mar 11, 20292.7ypatentEpivirlamivudineViiV Healthcare Company
- Mar 12, 20292.7ypatentNITROGLYCERINNITROGLYCERINAllegis Pharmaceuticals Inc
- Mar 12, 20292.7ypatentNevirapinenevirapineCamber Pharmaceuticals Inc
- Mar 12, 20292.7ypatentRiluzole RisingriluzoleRising Pharma Holdings Inc
- Mar 13, 20292.7ypatentDuaklir Pressair(aclidinium bromide + formoterol fumarate)Covis Group Sarl
- Mar 13, 20292.7ypatentTudorza Pressairaclidinium bromideCovis Group Sarl
- Mar 13, 20292.7ypatentAmiodarone Hydrochlorideamiodarone hydrochlorideTaro Pharmaceutical Laboratories Inc (Inactive)
- Mar 13, 20292.7ypatentBrliziobrexanolone$LPCNLipocine Inc.
- Mar 13, 20292.7ypatentFosphenytoin Sodiumfosphenytoin sodiumWockhardt USA LLC
- Mar 13, 20292.7ypatentEvomelamelphalanZhaoke Ophthalmology Ltd
- Mar 14, 20292.7ypatentPhentermine Hydrochloridephentermine hydrochloridePolygen Pharmaceuticals Inc
- Mar 22, 20292.7yNCETryvioaprocitentanIdorsia Pharmaceuticals US Inc
- Mar 24, 20292.7ypatentNamzaric(donepezil hydrochloride + memantine hydrochloride)$ABBVAbbVie Inc.
- Mar 24, 20292.7ypatentMemantine Hydrochloridememantine hydrochloridePolygen Pharmaceuticals Inc
- Mar 25, 20292.7ypatentMonoferricferric derisomaltosePharmacosmos Therapeutics Inc
- Mar 29, 20292.7ypatentQuillivant XRmethylphenidate hydrochlorideTris Pharma Inc
- Mar 29, 20292.7ypatentClonidine Hydrochlorideclonidine hydrochlorideFrontida Biopharm Inc
- Mar 29, 20292.7yNCEVoydeyadanicopanAlexion Pharmaceuticals Inc
- Apr 3, 20292.7yGAINZevteraceftobiprole medocarilInnoviva Specialty Therapeutics Inc
- Apr 15, 20292.8ypatentXiidralifitegrast$BLCOBausch & Lomb Corp
- Apr 16, 20292.8ypatentMultaqdronedarone hydrochlorideSanofi-Aventis US LLC
- Apr 21, 20292.8ypatentCiprofloxacinciprofloxacinBedford Laboratories
- Apr 23, 20292.8yNCEOjemdatovorafenib$DAWNDay One Biopharmaceuticals, Inc.
- Apr 26, 20292.8yNCEXolremdimavorixafor$XFORX4 Pharmaceuticals, Inc
sourced from FDA Orange Book · approved drugs only · biologics + biosimilars excluded (those live in the Purple Book — coming soon)